Literature DB >> 31635560

Enhancing the Assessment of Resiliency to Suicide Ideation among Older Adults: The Development and Initial Validation of the Reasons for Living-Suicide Resiliency Scale (RFL-SR).

Sonia Wadhwa1, Marnin J Heisel1,2,3,4.   

Abstract

Objectives: To derive a brief late-life suicide resiliency scale from the 69-item Reasons for Living Scale-Older Adult version (RFL-OA).
Methods: We conducted a series of secondary analyses of RFL-OA data (N = 204) from a dataset combining: 1. A follow-up assessment of nursing home residents in the Geriatric Suicide Ideation Scale (GSIS) development study; 2. A trial of Interpersonal Psychotherapy (IPT) with suicidal older adults; 3. A longitudinal study of risk and resiliency to late-life suicide ideation. We specifically assessed the distributions of RFL-OA items and their associations with suicide ideation and behavior to create an RFL-Suicide Resiliency subscale (RFL-SR); we then tested the psychometric properties of this measure's items drawn from the larger RFL-OA.
Results: Nine RFL-OA items were significantly associated with suicide ideation and history of suicide behavior and were not highly correlated with social desirability. Psychometric analyses supported the internal consistency, test-retest reliability, and construct validity of this scale.Conclusions: The items of the RFL-SR demonstrated strong psychometric properties with older adults in clinical and community settings.Clinical Implications: The RFL-SR may make a useful addition to suicide risk assessment in gerontological research and clinical practice.

Keywords:  RFL; Suicide risk; assessment; older adults; psychological resiliency; reasons for living; screening; suicide ideation

Mesh:

Year:  2019        PMID: 31635560     DOI: 10.1080/07317115.2019.1675840

Source DB:  PubMed          Journal:  Clin Gerontol        ISSN: 0731-7115            Impact factor:   2.619


  1 in total

Review 1.  Suicide resilience: A concept analysis.

Authors:  Xinlu Wang; Zhongqiu Lu; Chaoqun Dong
Journal:  Front Psychiatry       Date:  2022-09-26       Impact factor: 5.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.